Congratulations to all at mySugr and their partners at Roche for sealing an incredible deal! mySugr will remain an open platform while integrating further with Roche products, a win-win for all involved - especially users.
I was pleased to help with PR for the US launch of mySugr a few years ago. I've personally recommended it to dozens of people over the years. Its rich features, intuitive interface and ability to pick up data passively from certain devices go a long way to reducing the tedium of logging. In contrast, Roche's diabetes management software offerings have always seemed complex to me, both in terms of their technical operation and how they display data.
Here's hoping the tie-up with mySugr will mean the next generation of Roche data management offers both an amazing user experience and awesome data visualisation.